Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 51873 

Issued: November 3, 2017. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2017–24323 Filed 11–7–17; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–471F] 

Established Aggregate Production 

Quotas for Schedule I and II Controlled 

Substances and Assessment of 

Annual Needs for the List I Chemicals 

Ephedrine, Pseudoephedrine, and 

Phenylpropanolamine for 2018 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: Final order. 

SUMMARY: This final order establishes 

the initial 2018 aggregate production 

quotas for controlled substances in 

schedules I and II of the Controlled 

Substances Act and the assessment of 

annual needs for the list I chemicals 

ephedrine, pseudoephedrine, and 

phenylpropanolamine. 

APPLICABLE DATE: Applicable November 

8, 2017. 

FOR FURTHER INFORMATION CONTACT: 

Michael J. Lewis, Diversion Control 

Division, Drug Enforcement 

Administration, 8701 Morrissette Drive, 

Springfield, VA 22152, Telephone: (202) 

598–6812. 

SUPPLEMENTARY INFORMATION: 

Legal Authority 

Section 306 of the Controlled 

Substances Act (CSA) (21 U.S.C. 826) 

requires the Attorney General to 

establish aggregate production quotas 

for each basic class of controlled 

substance listed in schedules I and II 

and for the list I chemicals ephedrine, 

pseudoephedrine, and 

phenylpropanolamine. The Attorney 

General has delegated this function to 

the Administrator of the DEA pursuant 

to 28 CFR 0.100. 

Background 

The 2018 aggregate production quotas 

and assessment of annual needs 

represent those quantities of schedule I 

and II controlled substances and the list 

I chemicals ephedrine, 

pseudoephedrine, and 

phenylpropanolamine that may be 

manufactured in the United States in 

2018 to provide for the estimated 

medical, scientific, research, industrial 

needs of the United States, lawful 

export requirements, and the 

establishment and maintenance of 

reserve stocks. These quotas include 

imports of ephedrine, pseudoephedrine, 

and phenylpropanolamine, but do not 

include imports of controlled 

substances for use in industrial 

processes. 

On August 7, 2017, a notice titled 

‘‘Proposed Aggregate Production Quotas 

for Schedule I and II Controlled 

Substances and Assessment of Annual 

Needs for the List I Chemicals 

Ephedrine, Pseudoephedrine, and 

Phenylpropanolamine for 2018’’ was 

published in the Federal Register. 82 FR 

36830. This notice proposed the 2018 

aggregate production quotas for each 

basic class of controlled substance listed 

in schedules I and II and the 2018 

assessment of annual needs for the list 

I chemicals ephedrine, 

pseudoephedrine, and 

phenylpropanolamine. All interested 

persons were invited to comment on or 

object to the proposed aggregate 

production quotas and the proposed 

assessment of annual needs on or before 

September 6, 2017. 

Comments Received 

Within the public comment period, 

the DEA received seventeen comments 

from three DEA-registered 

manufacturers regarding sixteen 

different schedule I and II controlled 

substances and one comment from a 

DEA-registered manufacturer regarding 

the proposed assessment of annual 

needs for the list I chemical 

phenylpropanolamine (for conversion). 

Commenters stated the proposed 

aggregate production quotas for 4- 

anilino-n-phenethyl-4-piperadine 

(ANPP), amphetamine (for conversion), 

codeine (for sale), diphenoxylate, 

fentanyl, gamma hydroxybutyric acid, 

hydrocodone (for sale), 

lisdexamfetamine, methadone, 

methadone-intermediate, 

methylphenidate, morphine (for 

conversion), morphine (for sale), 

oxycodone (for sale), oxymorphone (for 

sale), sufentanil, as well as the proposed 

assessment of annual needs for 

phenylpropanolamine (for conversion), 

were insufficient to provide for the 

estimated medical, scientific, research, 

and industrial needs of the United 

States, export requirements, and the 

establishment and maintenance of 

reserve stocks. These comments were 

considered in setting the final 2018 

Aggregate Production Quotas as 

discussed below. 

In addition to these seventeen 

comments, the DEA received one 

comment from a DEA-registered 

manufacturer seeking clarification on 

whether DEA considers manufacturing 

at outsourcing facilities when 

determining the Aggregate Production 

Quotas. The DEA notes that it is the 

responsibility of all DEA-registered 

dosage form manufacturers to submit 

quota applications by April 1, in order 

for their individual business practices to 

be considered when the DEA proposes 

the Aggregate Production Quota for the 

following year. 21 CFR 1303.12(b). 

These quota applications and comments 

with discrete data regarding the 

quantities of the basic classes of 

schedule I or II controlled substances 

received during the comment period for 

the proposed Aggregate Production 

Quotas are taken into consideration 

before establishing the values presented 

in this Final Order. This DEA-registered 

manufacturer provided no quantitative 

data supporting the position that the 

proposed quota for 2018 will adversely 

impact outsourcing facilities for DEA to 

consider. The DEA also received one 

hundred five comments that expressed 

concern that DEA’s proposed reduction 

of opioids by twenty percent would 

adversely impact the availability of pain 

relieving prescription drugs for people 

with chronic pain. These comments 

were general in nature, and raised issues 

of specific medical illnesses and 

medical treatment, and therefore are 

outside of the scope of this Final Order 

for 2018. As a result, these one hundred 

and six comments did not provide new 

discrete data for consideration, and do 

not impact the original analysis 

involved in establishing the 2018 

aggregate production quotas. 

Determination of 2018 Aggregate 

Production Quotas and Assessment of 

Annual Needs 

In determining the 2018 aggregate 

production quotas and assessment of 

annual needs, the DEA has taken into 

consideration the above comments 

along with the factors set forth in 21 

CFR 1303.11 and 21 CFR 1315.11, in 

accordance with 21 U.S.C. 826(a), and 

other relevant factors, including the 

2017 manufacturing quotas, current 

2017 sales and inventories, anticipated 

2018 export requirements, industrial 

use, additional applications for 2018 

quotas, as well as information on 

research and product development 

requirements. Based on all of the above, 

the Administrator is adjusting the 2018 

aggregate production quotas for 2-(4- 

bromo-2,5-dimethoxyphenyl)-n-(2- 

methoxybenzyl) ethanamine, 3,4,5- 

trimethoxy amphetamine, 4-bromo-2,5- 

dimethoxy-amphetamine, acryl 

fentanyl, alfentanil, amobarbital, 

methylphenidate, and nabilone, are 

warranted. Adjustment to the proposed 

assessment of annual needs for 


ethrower on DSK3G9T082PROD with NOTICES
51874 Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 

pseudoephedrine (for sale) was also 

determined to be warranted. This final 

order reflects those adjustments. 

Regarding 4-anilino-n-phenethyl-4- 

piperadine (ANPP), amphetamine (for 

conversion), codeine (for sale), 

diphenoxylate, fentanyl, gamma 

hydroxybutyric acid, hydrocodone (for 

sale), lisdexamfetamine, methadone, 

methadone-intermediate, morphine (for 

conversion), morphine (for sale), 

oxycodone (for sale), oxymorphone (for 

sale), sufentanil, and 

phenylpropanolamine (for conversion), 

the DEA has determined the proposed 

aggregate production quotas and 

assessment of annual needs are 

sufficient to provide for the 2018 

estimated medical, scientific, research, 

industrial needs of the United States, 

export requirements, and the 

establishment and maintenance of 

reserve stocks. This final order 

establishes these aggregate production 

quotas and assessment of annual needs 

at the same amounts as proposed. 

In accordance with 21 U.S.C. 826, 21 

CFR 1303.11, and 21 CFR 1315.11, the 

Administrator hereby establishes the 

2018 aggregate production quotas for the 

following schedule I and II controlled 

substances and the 2018 assessment of 

annual needs for the list I chemicals 

ephedrine, pseudoephedrine, and 

phenylpropanolamine, expressed in 

grams of anhydrous acid or base, as 

follows: 

Basic class 

2018 

Established 

quotas 

(g) 

Temporarily Scheduled Substances 

Acryl fentanyl ....................................................................................................................................................................................... 25 

Schedule I 

1-(1-Phenylcyclohexyl)pyrrolidine ........................................................................................................................................................ 10 

1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201) ............................................................................................................................ 30 

1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) ........................................................................................................................... 30 

1-[1-(2-Thienyl)cyclohexyl]piperidine ................................................................................................................................................... 15 

1-Benzylpiperazine .............................................................................................................................................................................. 25 

1-Methyl-4-phenyl-4-propionoxypiperidine ........................................................................................................................................... 2 

2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) ........................................................................................................................... 30 

2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) ........................................................................................................................ 30 

2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) .......................................................................................................................... 30 

2-(2,5-Dimethoxy-4-n-propylphenyl)ethanamine (2C-P) ...................................................................................................................... 30 

2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) ....................................................................................................................................... 30 

2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) ........................ 30 

2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) ........................................................................................................................ 30 

2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) ........................ 25

2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) .............................................................................................................................. 30 

2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5) .................................. 30 

2,5-Dimethoxy-4-ethylamphetamine (DOET) ...................................................................................................................................... 25 

2,5-Dimethoxy-4-n-propylthiophenethylamine ..................................................................................................................................... 25 

2,5-Dimethoxyamphetamine ................................................................................................................................................................ 25 

2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) ................................................................................................................ 30 

2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) .......................................................................................................... 30 

3,4,5-Trimethoxyamphetamine ............................................................................................................................................................ 30 

3,4-Methylenedioxyamphetamine (MDA) ............................................................................................................................................ 55 

3,4-Methylenedioxymethamphetamine (MDMA) ................................................................................................................................. 50 

3,4-Methylenedioxy-N-ethylamphetamine (MDEA) ............................................................................................................................. 40 

3,4-Methylenedioxy-N-methylcathinone (methylone) .......................................................................................................................... 40 

3,4-Methylenedioxypyrovalerone (MDPV) ........................................................................................................................................... 35 

3-FMC; 3-Fluoro-N-methylcathinone ................................................................................................................................................... 25 

3-Methylfentanyl ................................................................................................................................................................................... 30 

3-Methylthiofentanyl ............................................................................................................................................................................. 30 

4-Bromo-2,5-dimethoxyamphetamine (DOB) ...................................................................................................................................... 30 

4-Bromo-2,5-dimethoxyphenethylamine (2-CB) .................................................................................................................................. 25 

4-Fluoroisobutyryl fentanyl ................................................................................................................................................................... 30 

4-FMC; Flephedrone ............................................................................................................................................................................ 25 

4-MEC; 4-Methyl-N-ethylcathinone ...................................................................................................................................................... 25 

4-Methoxyamphetamine ...................................................................................................................................................................... 150 

4-Methyl-2,5-dimethoxyamphetamine (DOM) ...................................................................................................................................... 25 

4-Methylaminorex ................................................................................................................................................................................ 25 

4-Methyl-N-methylcathinone (mephedrone) ........................................................................................................................................ 45 

4-Methyl-a-pyrrolidinopropiophenone (4-MePPP) ............................................................................................................................... 25 

5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol ......................................................................................................... 50 

5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) ........................... 40 

5F-ADB; 5F-MDMB-PINACA (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ............................ 30 

5F-AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ................................................................... 30 

5F-APINACA; 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ........................................................ 30 

5-Fluoro-PB-22; 5F-PB-22 ................................................................................................................................................................... 20 

5-Fluoro-UR144, XLR11 ([1-(5-fluoro-pentyl)-1Hindol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ............................................ 25 

5-Methoxy-3,4-methylenedioxyamphetamine ...................................................................................................................................... 25 

5-Methoxy-N,N-diisopropyltryptamine .................................................................................................................................................. 25 

5-Methoxy-N,N-dimethyltryptamine ..................................................................................................................................................... 25 


ethrower on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 51875 

Basic class 

2018 

Established 

quotas 

(g) 

AB-CHMINACA .................................................................................................................................................................................... 30 

AB-FUBINACA ..................................................................................................................................................................................... 50 

AB-PINACA .......................................................................................................................................................................................... 30 

ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .................................. 30 

Acetyl Fentanyl .................................................................................................................................................................................... 100 

Acetyl-alpha-methylfentanyl ................................................................................................................................................................. 30 

Acetyldihydrocodeine ........................................................................................................................................................................... 30 

Acetylmethadol .................................................................................................................................................................................... 2 

Acryl Fentanyl ...................................................................................................................................................................................... 25 

ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ...................................................... 50 

AH-7921 ............................................................................................................................................................................................... 30 

Allylprodine .......................................................................................................................................................................................... 2 

Alphacetylmethadol .............................................................................................................................................................................. 2 

alpha-Ethyltryptamine .......................................................................................................................................................................... 25 

Alphameprodine ................................................................................................................................................................................... 2 

Alphamethadol ..................................................................................................................................................................................... 2 

alpha-Methylfentanyl ............................................................................................................................................................................ 30 

alpha-Methylthiofentanyl ...................................................................................................................................................................... 30 

alpha-Methyltryptamine (AMT) ............................................................................................................................................................ 25 

alpha-Pyrrolidinobutiophenone (a-PBP) .............................................................................................................................................. 25 

alpha-Pyrrolidinopentiophenone (a-PVP) ............................................................................................................................................ 25 

Aminorex .............................................................................................................................................................................................. 25 

APINCA, AKB48 (N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ......................................................................................... 25 

Benzylmorphine ................................................................................................................................................................................... 30 

Betacetylmethadol ............................................................................................................................................................................... 2 

beta-Hydroxy-3-methylfentanyl ............................................................................................................................................................ 30 

beta-Hydroxyfentanyl ........................................................................................................................................................................... 30 

beta-Hydroxythiofentanyl ..................................................................................................................................................................... 30 

Betameprodine ..................................................................................................................................................................................... 2 

Betamethadol ....................................................................................................................................................................................... 4 

Betaprodine .......................................................................................................................................................................................... 2 

Bufotenine ............................................................................................................................................................................................ 3 

Butylone ............................................................................................................................................................................................... 25 

Butyryl fentanyl .................................................................................................................................................................................... 30 

Cathinone ............................................................................................................................................................................................. 24 

Codeine methylbromide ....................................................................................................................................................................... 30 

Codeine-N-oxide .................................................................................................................................................................................. 192 

Desomorphine ...................................................................................................................................................................................... 25 

Diethyltryptamine ................................................................................................................................................................................. 25 

Difenoxin .............................................................................................................................................................................................. 8,225 

Dihydromorphine .................................................................................................................................................................................. 1,000,160 

Dimethyltryptamine .............................................................................................................................................................................. 35 

Dipipanone ........................................................................................................................................................................................... 5 

Etorphine .............................................................................................................................................................................................. 30 

Fenethylline .......................................................................................................................................................................................... 30 

Furanyl fentanyl ................................................................................................................................................................................... 30 

gamma-Hydroxybutyric acid ................................................................................................................................................................ 37,130,000 

Heroin .................................................................................................................................................................................................. 45 

Hydromorphinol .................................................................................................................................................................................... 40 

Hydroxypethidine ................................................................................................................................................................................. 2 

Ibogaine ............................................................................................................................................................................................... 30 

JWH-018 and AM678 (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................................................................... 35 

JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ........................................................................................................................................... 45 

JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................................................ 45 

JWH-081 (1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole) ....................................................................................................................... 30 

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) ........................................................................................................................... 30 

JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ............................................................................................................... 35 

JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) ............................................................................................................................ 30 

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) ........................................................................................................................ 30 

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) ............................................................................................................................ 30 

Lysergic acid diethylamide (LSD) ........................................................................................................................................................ 40 

MAB-CHMINACA; ADB-CHMINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- 

carboxamide) .................................................................................................................................................................................... 30 

MDMB-CHMICA; MMB-CHMINACA(methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ................. 30 

MDMB-FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ........................................... 30 

Marihuana ............................................................................................................................................................................................ 443,680 

Mecloqualone ....................................................................................................................................................................................... 30 

Mescaline ............................................................................................................................................................................................. 25 

Methaqualone ...................................................................................................................................................................................... 60 

Methcathinone ..................................................................................................................................................................................... 25 

Methyldesorphine ................................................................................................................................................................................. 5 


ethrower on DSK3G9T082PROD with NOTICES
51876 Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 

Basic class 

2018 

Established 

quotas 

(g) 

Methyldihydromorphine ........................................................................................................................................................................ 2 

Morphine methylbromide ..................................................................................................................................................................... 5 

Morphine methylsulfonate .................................................................................................................................................................... 5 

Morphine-N-oxide ................................................................................................................................................................................ 150 

N,N-Dimethylamphetamine .................................................................................................................................................................. 25 

Naphyrone ........................................................................................................................................................................................... 25 

N-Ethyl-1-phenylcyclohexylamine ........................................................................................................................................................ 5 

N-Ethylamphetamine ........................................................................................................................................................................... 24 

N-Hydroxy-3,4-methylenedioxyamphetamine ...................................................................................................................................... 24 

Noracymethadol ................................................................................................................................................................................... 2 

Norlevorphanol ..................................................................................................................................................................................... 55 

Normethadone ..................................................................................................................................................................................... 2 

Normorphine ........................................................................................................................................................................................ 40 

Para-fluorofentanyl ............................................................................................................................................................................... 25 

Parahexyl ............................................................................................................................................................................................. 5 

PB-22; QUPIC ..................................................................................................................................................................................... 20 

Pentedrone .......................................................................................................................................................................................... 25 

Pentylone ............................................................................................................................................................................................. 25 

Phenomorphan .................................................................................................................................................................................... 2 

Pholcodine ........................................................................................................................................................................................... 5 

Psilocybin ............................................................................................................................................................................................. 30 

Psilocyn ................................................................................................................................................................................................ 50 

SR-18 and RCS-8 (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) ........................................................................................... 45 

SR-19 and RCS-4 (1-Pentyl-3-[(4-methoxy)-benzoyl]indole) .............................................................................................................. 30 

Tetrahydrocannabinols ........................................................................................................................................................................ 384,460 

Thiofentanyl ......................................................................................................................................................................................... 25 

THJ-2201 ( [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .................................................................................... 30 

Tilidine .................................................................................................................................................................................................. 25 

Trimeperidine ....................................................................................................................................................................................... 2 

UR-144 (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ...................................................................................... 25 

U-47700 ............................................................................................................................................................................................... 30 

Schedule II 

1-Phenylcyclohexylamine .................................................................................................................................................................... 4 

1-Piperidinocyclohexanecarbonitrile .................................................................................................................................................... 4 

4-Anilino-N-phenethyl-4-piperidine (ANPP) ......................................................................................................................................... 1,342,320 

Alfentanil .............................................................................................................................................................................................. 6,200 

Alphaprodine ........................................................................................................................................................................................ 2 

Amobarbital .......................................................................................................................................................................................... 20,100 

Amphetamine (for conversion) ............................................................................................................................................................ 11,280,000 

Amphetamine (for sale) ....................................................................................................................................................................... 39,856,000 

Carfentanil ............................................................................................................................................................................................ 20 

Cocaine ................................................................................................................................................................................................ 92,120 

Codeine (for conversion) ..................................................................................................................................................................... 15,040,000 

Codeine (for sale) ................................................................................................................................................................................ 40,015,800 

Dextropropoxyphene ............................................................................................................................................................................ 35 

Dihydrocodeine .................................................................................................................................................................................... 264,140 

Dihydroetorphine .................................................................................................................................................................................. 2 

Diphenoxylate (for conversion) ............................................................................................................................................................ 14,100 

Diphenoxylate (for sale) ....................................................................................................................................................................... 770,800 

Ecgonine .............................................................................................................................................................................................. 88,134 

Ethylmorphine ...................................................................................................................................................................................... 30 

Etorphine hydrochloride ....................................................................................................................................................................... 32 

Fentanyl ............................................................................................................................................................................................... 1,342,320 

Glutethimide ......................................................................................................................................................................................... 2 

Hydrocodone (for conversion) ............................................................................................................................................................. 114,680 

Hydrocodone (for sale) ........................................................................................................................................................................ 50,348,280 

Hydromorphone ................................................................................................................................................................................... 4,547,720 

Isomethadone ...................................................................................................................................................................................... 30 

Levo-alphacetylmethadol (LAAM) ........................................................................................................................................................ 5 

Levomethorphan .................................................................................................................................................................................. 30 

Levorphanol ......................................................................................................................................................................................... 12,126 

Lisdexamfetamine ................................................................................................................................................................................ 17,869,000 

Meperidine ........................................................................................................................................................................................... 2,717,540 

Meperidine Intermediate-A .................................................................................................................................................................. 5 

Meperidine Intermediate-B .................................................................................................................................................................. 30 

Meperidine Intermediate-C .................................................................................................................................................................. 5 

Metazocine ........................................................................................................................................................................................... 15 

Methadone (for sale) ........................................................................................................................................................................... 22,278,000 

Methadone Intermediate ...................................................................................................................................................................... 24,064,000 


ethrower on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 51877 

Basic class 

2018 

Established 

quotas 

(g) 

Methamphetamine ............................................................................................................................................................................... 1,446,754 

[846,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 564,000 grams for methamphetamine mostly for 

conversion to a schedule III product; and 36,754 grams for methamphetamine (for sale)] 

Methylphenidate ................................................................................................................................................................................... 64,600,000 

Morphine (for conversion) .................................................................................................................................................................... 4,089,000 

Morphine (for sale) .............................................................................................................................................................................. 33,958,440 

Nabilone ............................................................................................................................................................................................... 31,000 

Noroxymorphone (for conversion) ....................................................................................................................................................... 14,044,540 

Noroxymorphone (for sale) .................................................................................................................................................................. 376,000 

Opium (powder) ................................................................................................................................................................................... 84,600 

Opium (tincture) ................................................................................................................................................................................... 564,000 

Oripavine .............................................................................................................................................................................................. 24,534,000 

Oxycodone (for conversion) ................................................................................................................................................................ 2,453,400 

Oxycodone (for sale) ........................................................................................................................................................................... 95,692,000 

Oxymorphone (for conversion) ............................................................................................................................................................ 20,962,000 

Oxymorphone (for sale) ....................................................................................................................................................................... 3,395,280 

Pentobarbital ........................................................................................................................................................................................ 25,850,000 

Phenazocine ........................................................................................................................................................................................ 5 

Phencyclidine ....................................................................................................................................................................................... 35 

Phenmetrazine ..................................................................................................................................................................................... 25 

Phenylacetone ..................................................................................................................................................................................... 40 

Racemethorphan ................................................................................................................................................................................. 5 

Racemorphan ...................................................................................................................................................................................... 5 

Remifentanil ......................................................................................................................................................................................... 2,820 

Secobarbital ......................................................................................................................................................................................... 161,682 

Sufentanil ............................................................................................................................................................................................. 1,880 

Tapentadol ........................................................................................................................................................................................... 18,388,280 

Thebaine .............................................................................................................................................................................................. 94,000,000 

List I Chemicals 

Ephedrine (for conversion) .................................................................................................................................................................. 47,000 

Ephedrine (for sale) ............................................................................................................................................................................. 4,136,000 

Phenylpropanolamine (for conversion) ................................................................................................................................................ 14,100,000 

Phenylpropanolamine (for sale) ........................................................................................................................................................... 7,990,000 

Pseudoephedrine (for conversion) ...................................................................................................................................................... 40 

Pseudoephedrine (for sale) ................................................................................................................................................................. 180,000,000 

The Administrator also establishes 

aggregate production quotas for all other 

schedule I and II controlled substances 

included in 21 CFR 1308.11 and 

1308.12 at zero. In accordance with 21 

CFR 1303.13 and 21 CFR 1315.13, upon 

consideration of the relevant factors, the 

Administrator may adjust the 2018 

aggregate production quotas and 

assessment of annual needs as needed. 

Dated: November 1, 2017. 

Robert W. Patterson, 

Acting Administrator. 

[FR Doc. 2017–24306 Filed 11–7–17; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Foreign Claims Settlement 

Commission 

[F.C.S.C. Meeting and Hearing Notice No. 

10–17] 

Sunshine Act Meeting 

The Foreign Claims Settlement 

Commission, pursuant to its regulations 

(45 CFR part 503.25) and the 

Government in the Sunshine Act (5 

U.S.C. 552b), hereby gives notice in 

regard to the scheduling of open 

meetings as follows: 

THURSDAY, NOVEMBER 16, 2017: 10:00 

a.m.—Issuance of Proposed Decisions in 

claims against Iraq. 

STATUS: Open. 

All meetings are held at the Foreign 

Claims Settlement Commission, 600 E 

Street NW., Washington, DC. Requests 

for information, or advance notices of 

intention to observe an open meeting, 

may be directed to: Patricia M. Hall, 

Foreign Claims Settlement Commission, 

600 E Street NW., Suite 6002, 

Washington, DC 20579. Telephone: 

(202) 616–6975. 

Brian M. Simkin, 

Chief Counsel. 

[FR Doc. 2017–24361 Filed 11–6–17; 8:45 am] 

BILLING CODE 4410–BA–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the Clean Air 

Act 

On October 31, 2017, the Department 

of Justice lodged a proposed consent 

decree with the United States District 

Court for the District of Colorado in the 

lawsuit entitled United States of 

America and the State of Colorado v. 

PDC Energy, Inc., Civil Action No. 1:17– 

cv–01552–MSK–MJW. 

The lawsuit seeks injunctive relief 

and civil penalties for violations of the 

Clean Air Act, the Colorado Air 


ethrower on DSK3G9T082PROD with NOTICES